BiotechTube
Home/Pipeline/EV‑Endo

EV‑Endo

Endometriosis

PreclinicalActive

Key Facts

Indication
Endometriosis
Phase
Preclinical
Status
Active
Company
Cartherics

About Cartherics

Australian biotech delivering off‑the‑shelf CAR‑NK and EV immunotherapies for women’s cancers and endometriosis.

View full company profile

Therapeutic Areas

OncologyGynecologyImmunology

Other Endometriosis Drugs

DrugCompanyPhase
Promarker™EndoProteomics InternationalLate‑stage validation
Endometriosis ProgramCyclana BioDiscovery
Endometriosis Genetic StudyJuneau BiosciencesDiscovery
Potential Diagnostic DevelopmentJuneau BiosciencesResearch
Endometriosis Discovery ProgramMetri BioDiscovery
Endometriosis Test SuiteHeranova LifesciencesPre-clinical
EndomTestKephera DiagnosticsCommercial (LDT)
ENDO-205EndoCyclic TherapeuticsPhase 1
Undisclosed ImmunotherapyApheon BiosciencePreclinical
FMCFimmCytePre-clinical
ABC-201AbcelyPreclinical
ERβ Modulator ProgramCadenza BioPreclinical